oncology

Roche Pharma Acquires Ignyta for $1.7 billion

Roche Pharma Acquires Ignyta for $1.7 billion

Roche Holdings entered into a definitive agreement  with Ignyta Inc. (NASDAQ: RXDX) to acquire the biotech company specialized in the oncology field. Under the agreement, Roche agreed to purchase Ignyta at a price of $27.00 per share in cash. I..

Merck Acquires Rigontec for $550 Million

Merck Acquires Rigontec for $550 Million

Merck & Co. Inc. (NYSE: MRK) announced today its acquisition of German biotech start-up, Rigontec for approximately €464 million or $550 million to further advance studies and research in cancer treatment development.Merck agreed to pay &eu..

Novartis Immunocellular Therapy Approved by FDA

Novartis Immunocellular Therapy Approved by FDA

Novartis AG (NYSE: NVS) announced Wednesday that the US Food and Drug Administration (FDA) has approved Kymriah (TM)(tisagenlecleucel) suspension for intravenous infusion, the first chimeric antigen receptor T cell (CAR-T) therapy, for the treatment..

Clovis Oncology Inc. (NASDAQ: CLVS)Shares Spiked After Positive Phase 3 Data

Clovis Oncology Inc. (NASDAQ: CLVS)Shares Spiked After Positive Phase 3 Data

Clovis Oncology Inc. (NASDAQ: CLVS) is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. The company’s shares jumped ab..